Under the terms of the partnership deal between the companies, Hyloris will receive a share on any revenues related to product, such as royalties, license fees, milestone payments, The post AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV appeared first on Pharmaceutical Business review. … [Read more...]
GSK receives orphan drug designation for Benlysta to treat systemic sclerosis
Initially, the FDA approved Benlysta for the treatment of active systemic lupus erythematosus (SLE). GSK noted that it is the first and only approved biologic for SLE as The post GSK receives orphan drug designation for Benlysta to treat systemic sclerosis appeared first on Pharmaceutical Business review. … [Read more...]
NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures
The negotiated price for NHS use was not disclosed. … [Read more...]
The Circle of Vision
Pharm Exec details the career of Rajesh K. Rajpal, MD, the chief medical officer and global head of clinical and medical affairs at J&J Vision. … [Read more...]
TScan Therapeutics receives FDA clearance for IND applications
Serving as the primary IND for TScan’s solid tumour programme, T-Plex will enable customised combinations of T cell receptor (TCR)-engineered T cell therapies (TCR-T) to be given to The post TScan Therapeutics receives FDA clearance for IND applications appeared first on Pharmaceutical Business review. … [Read more...]